Hepatic stem cell
transplantation (HCTx) is promising as bridge towards organ transplantation for
the treatment of decompensated liver cirrhosis.
Fortification of
hepatic progenitors from the emergent human liver, with minimum rejection in
transplantation remains a major dare for the improvement of therapeutic
approaches to liver disorders.
Human fetal liver
derived hepatic progenitor’s cells recommend an imperative therapy for clinical
application. Several investigators have shown that decreased phenotypic
expression HLA-II markers in the EpCAM +ve cells isolated from the second
trimester fetal liver.
No comments:
Post a Comment